People · Operator

Gilles S. Spenlehauer

Named in public records as an officer, director or promoter · active 2024–2026 · Other Health Care

1
Companies
4
Filings
$6.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Carmell CorpOther Health CareSeed$6.0M$427K2024
Operator network

Gilles S. Spenlehauer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Rajiv Shukla · 2 companies · 1 sharedRajiv ShuklaBryan Cassaday · 1 companies · 1 sharedBryan CassadayBryan S. Cassaday · 1 companies · 1 sharedBryan S. CassadayDavid S. Anderson · 1 companies · 1 sharedDavid S. AndersonJanakiram Ajjarapu · 1 companies · 1 sharedJanakiram AjjarapuKathryn Gregory · 1 companies · 1 sharedKathryn GregoryKathryn S. Gregory · 1 companies · 1 sharedKathryn S. GregoryKendra S. Bracken-Ferguson · 1 companies · 1 sharedKendra S. Bracken…Patrick S. Sturgeon · 1 companies · 1 sharedPatrick S. Sturge…Rajiv S. Shukla · 1 companies · 1 sharedRajiv S. ShuklaRichard S. Upton · 1 companies · 1 sharedRichard S. UptonScott Frisch · 1 companies · 1 sharedScott FrischScott S. Frisch · 1 companies · 1 sharedScott S. FrischCarmell Corp · $6.0M raisedCarmell CorpGilles S. SpenlehauerGS
Gilles S. Spenlehauer Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Gilles S. Spenlehauer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Rajiv Shukla12
Kathryn S. Gregory11
Janakiram Ajjarapu11
Patrick S. Sturgeon11
Scott S. Frisch11
Bryan S. Cassaday11
Richard S. Upton11
Scott Frisch11
Bryan Cassaday11
Kathryn Gregory11
Kendra S. Bracken-Ferguson11
Rajiv S. Shukla11
David S. Anderson11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.